What is the appropriate work‑up and initial management for a patient with macrocytic anemia (hemoglobin 10 g/dL, hematocrit 33.5 %, mean corpuscular volume 112.8 fL) and marked neutrophilic leukocytosis (white blood cell count 20.37 ×10^3/µL, neutrophils 87 %)?

Urgent Evaluation for Dual Pathology: Macrocytic Anemia with Marked Leukocytosis

This patient requires immediate peripheral blood smear review and urgent hematology consultation to exclude acute leukemia, myelodysplastic syndrome (MDS), or other hematologic malignancy, as the combination of macrocytic anemia (MCV 112.8 fL) with marked neutrophilic leukocytosis (WBC 20.37 × 10³/µL, 87% neutrophils) and elevated RDW (21.4%) suggests serious bone marrow pathology rather than simple nutritional deficiency.

Critical Initial Assessment

The laboratory findings reveal two distinct abnormalities that must be evaluated simultaneously:

1. Macrocytic Anemia Work-Up

Minimum essential tests 1:

• Reticulocyte count (most critical next step to distinguish production vs. destruction)
• Vitamin B12 level
• Folate level
• Serum ferritin and transferrin saturation
• LDH, indirect bilirubin, and haptoglobin (to evaluate hemolysis)
• Thyroid function tests
• Liver function tests

Peripheral blood smear examination is mandatory 2 to look for:

• Hypersegmented neutrophils (≥5 lobes) indicating megaloblastic anemia
• Macro-ovalocytes
• Blast cells or dysplastic features suggesting MDS
• Abnormal white cell morphology

2. Leukocytosis Evaluation

The marked neutrophilic leukocytosis (absolute neutrophil count 17.72 × 10³/µL) requires urgent assessment 3:

Critical distinction needed: Reactive leukemoid reaction vs. myeloid malignancy

Examine peripheral smear for 3:

• Blast count and blast equivalents (promyelocytes, myelocytes)
• Toxic granulation, Döhle bodies, or vacuolization (suggests infection/inflammation)
• Dysplastic features in neutrophils
• Basophilia (present: 0%, which argues against chronic myeloid leukemia)
• Left shift with immature granulocytes

Additional tests needed:

• CRP/ESR to assess for infection or inflammation
• Blood cultures if febrile
• Imaging to identify occult infection or malignancy

Algorithmic Approach to Diagnosis

Step 1: Reticulocyte Count Interpretation 2, 1

If reticulocyte count is LOW or inappropriately normal:

• Indicates decreased RBC production
• Suggests: Vitamin B12/folate deficiency, MDS, bone marrow failure, or drug effect
• Proceed to bone marrow biopsy if nutritional deficiencies excluded

If reticulocyte count is HIGH:

• Indicates hemolysis or recent blood loss
• Check hemolysis markers (LDH, haptoglobin, indirect bilirubin, Coombs test)

Step 2: Vitamin B12 and Folate Assessment 1

Macrocytosis (MCV >100 fL) most commonly indicates 2:

• Vitamin B12 deficiency (most common megaloblastic cause)
• Folate deficiency
• Alcoholism
• MDS
• Medications (hydroxyurea, azathioprine, anticonvulsants)
• Hypothyroidism

If B12 <200 pg/mL or folate deficient: Identify underlying cause (pernicious anemia, malabsorption, dietary)

If B12 and folate normal with persistent macrocytosis: Bone marrow examination mandatory to exclude MDS 4, 5

Step 3: Bone Marrow Evaluation - URGENT if:

Absolute indications for bone marrow biopsy 1:

• Unexplained macrocytosis after nutritional work-up
• Presence of blasts on peripheral smear
• Pancytopenia or bicytopenia
• Dysplastic features on blood smear
• Persistent unexplained leukocytosis
• High clinical suspicion for MDS or acute leukemia

The combination of macrocytic anemia with marked leukocytosis and elevated RDW (21.4%) is particularly concerning for MDS 4, 5, 6, which can present with:

• Macrocytosis (54.7% of MDS patients) 6
• Elevated RDW (84.7% of MDS patients) 6
• Variable cytopenias or cytoses
• Risk of progression to acute myeloid leukemia

Management Priorities

Immediate Actions:

1. Peripheral blood smear review by hematopathologist - same day
2. Hematology consultation - urgent (within 24-48 hours)
3. Complete laboratory panel as outlined above
4. Assess for infection given marked leukocytosis:
   • Detailed history for fever, localizing symptoms
   • Physical examination for infection source
   • Consider imaging if clinically indicated

Supportive Care:

• RBC transfusion only if hemoglobin <7-8 g/dL or symptomatic 7, 4
• Avoid empiric vitamin supplementation until deficiency confirmed (can mask diagnosis)
• Monitor closely for clinical deterioration

Critical Pitfalls to Avoid

1. Do not assume simple B12/folate deficiency without excluding malignancy - the leukocytosis is atypical for pure nutritional deficiency 8

2. Do not delay bone marrow biopsy if initial work-up is unrevealing - MDS can present with isolated macrocytosis and variable blood counts 4, 5

3. Do not overlook coexisting conditions - severe B12 deficiency can mask underlying myeloproliferative neoplasms through intramedullary hemolysis 8

4. High RDW (21.4%) suggests heterogeneous RBC population - may indicate dual pathology (e.g., combined deficiency states or MDS with dysplastic erythropoiesis) 1, 6

5. Macrocytosis can be masked if concurrent microcytic process exists (iron deficiency, thalassemia) - the elevated RDW supports this possibility 1